Lilly announces winners of inaugural Leonard Award, a global program celebrating 100 years of innovation in diabetes care
The Leonard Award was inspired by the life of
- Teen/young adult:
Drew Mendelowof Gaithersburg, Maryland, United States, for work developing the T1D1 app, which helps people with diabetes calculate and log key metrics and easily send data to their diabetes care team.
- Advocate/advocacy professional:
Sana Ajmal, PhD of Rawalpindi, Punjab, Pakistan, for work as the founder and executive director of Meethi Zingagi, a non-profit organization that aims to improve the lives of people with diabetes.
- Endocrinologist/primary care physician:
Giuseppina Chierici, MD of Milano, Italy, for work starting, "Portiamo a casa un sorriso," a project that provides free medical home care assistance and advice for people with diabetes in need.
- Diabetes educator/nurse:
Vanita Pais, RD, CDE of Toronto, Ontario, Canada, for work on food skills programs and workshops for children with type 1 diabetes.
James Shapiro, MD, PhD of Edmonton, Alberta, Canada, for work developing the Edmonton Protocol for islet cell transplantation, which has been carried out more than 700 times and aims to improve the care of people with diabetes.
The winners from each category were selected by an external judges' panel comprised of esteemed leaders in diabetes care. The panel evaluated more than 70 submissions of an original project, innovation or effort that addresses either an important need or challenge in the management of diabetes or aims to support the community.
"On this upcoming World Diabetes Day, and in honor of the 100th anniversary of the discovery of insulin,
The Leonard Award external judges' panel included the following:
- Tadej Battelino, MD, PhD, Consultant and Head of
Department of Pediatric and Adolescent Endocrinology, UMC Ljubljana
- Amalia Gastaldelli, Research Director,
Institute of Clinical Physiology, CNR Mariana Gomez, Director, Emerging Markets, Beyond Type 1 Irl B. Hirsch, MD, Professor of Medicine, UW Medicine Diabetes Institute Nicole Johnson, DrPH, MPH, MA, Vice President, Science & Health Care, American Diabetes Association Sarah Linklater, PhD, Chief Scientific Officer, JDRF Canada Kenneth P. Moritsugu, MD, MPH, FACPM, RADM, USPHS (Retired) Anna Norton, MS, CEO, DiabetesSisters Navnit (Niti) Kaur Pall, MD, President, International Diabetes Federation Europe Leonard Glass, MD, F.A.C.E., Vice President, LillyDiabetes Global Medical Affairs, Eli Lilly and Company
The panel reviewed entries based on several criteria, including impact, novelty, feasibility and ability to advance
"We are honored to be the beneficiary of the outstanding work exhibited by the Leonard Award winners. I'm thankful for and inspired by the outstanding efforts of these individuals and their dedication to making a difference for people living with diabetes," said Dr.
To learn more about the Leonard Award, the winning individuals and their work, please visit Lilly.com/LeonardAward.
Approximately 34 million Americans1 (just over 1 in 10) and an estimated 463 million adults worldwide2 have diabetes. Type 2 diabetes is the most common type internationally, accounting for an estimated 90 to 95 percent of all diabetes cases in
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing we strive to make life better for people affected by diabetes and related conditions. We work to deliver breakthrough outcomes through innovative solutions—from medicines and technologies to support programs and more. For the latest updates, visit http://www.lillydiabetes.com/ or follow us on Twitter: @LillyDiabetes and Facebook: LillyDiabetesUS.
Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at lilly.com and lilly.com/newsroom. P-LLY
Lilly Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about Lilly's Leonard Award, including its objectives, selection criteria, nomination process, intended donations, and related activities, and reflects Lilly's current beliefs and expectations. There can be no assurance that the Leonard Award will achieve Lilly's objectives or that
Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept. of Health and Human Services; 2020. International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: International Diabetes Federation, 2019. Available at: http://diabetesatlas.org.
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-announces-winners-of-inaugural-leonard-award-a-global-program-celebrating-100-years-of-innovation-in-diabetes-care-301421104.html